Clinigence Holdings, Inc. reported unaudited impairment charges for the third quarter ended September 30, 2022. For the quarter, the company reported goodwill impairment of $408,466,575.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 USD | -9.52% | +51.15% | +2.50% |
06-27 | Nutex Health to Implement 1-for-10 Reverse Stock Split | MT |
06-24 | Nutex Health Inc.(NasdaqCM:NUTX) dropped from S&P Global BMI Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.32% | 84.59B | |
-21.99% | 77.33B | |
+2.32% | 27.12B | |
-5.06% | 18.19B | |
+6.95% | 18.49B | |
+7.69% | 16.49B | |
+76.20% | 13.55B | |
+76.56% | 13.03B | |
-26.84% | 12.43B |
- Stock Market
- Equities
- NUTX Stock
- NUTX Stock
- News Nutex Health Inc.
- Clinigence Holdings, Inc. Reports Unaudited Impairment Charges for the Third Quarter Ended September 30, 2022